中医临床研究
中醫臨床研究
중의림상연구
Clinical Journal of Chinese Medicine
2015年
27期
40-42
,共3页
免疫因子联合疗法%免疫甲状腺疾病%瘿病%中医治疗甲状腺疾病
免疫因子聯閤療法%免疫甲狀腺疾病%癭病%中醫治療甲狀腺疾病
면역인자연합요법%면역갑상선질병%영병%중의치료갑상선질병
Combined immune factor therapy%Immune thyroid diseases%Ying disease%TCM treatment for thyroid disease
目的:观察运用免疫因子联合疗法治疗免疫性甲状腺疾病的临床疗效。方法:严格按照纳入标准将116例自身免疫性甲状腺疾病患者随机分2组,治疗组58例,对照组58例。采用免疫因子联合疗法治疗,采用常规抗甲状腺药物治疗。两组疗程均为3个月。观察患者治疗前后临床症状、体征和实验室化验、检查指标变化。结果:①两组患者治疗后有效率分别是98.3%和53.4%,临床治愈率分别是94.8%和43.1%,治疗组明显优于对照组,且差异性有统计学意义(P<0.05)。②免疫因子联合疗法治疗后甲状腺抗体下降(P<0.05)③免疫因子联合疗法治疗后可改善和消除免疫性甲状腺疾病各种临床症状、体征,治疗组优于对照组。结论:两组治疗方法对免疫性甲状腺疾病都有一定的改善作用,但治疗组总有效率和治愈率明显优于对照组。说明免疫因子联合疗法治疗免疫性甲状腺疾病疗效更佳。
目的:觀察運用免疫因子聯閤療法治療免疫性甲狀腺疾病的臨床療效。方法:嚴格按照納入標準將116例自身免疫性甲狀腺疾病患者隨機分2組,治療組58例,對照組58例。採用免疫因子聯閤療法治療,採用常規抗甲狀腺藥物治療。兩組療程均為3箇月。觀察患者治療前後臨床癥狀、體徵和實驗室化驗、檢查指標變化。結果:①兩組患者治療後有效率分彆是98.3%和53.4%,臨床治愈率分彆是94.8%和43.1%,治療組明顯優于對照組,且差異性有統計學意義(P<0.05)。②免疫因子聯閤療法治療後甲狀腺抗體下降(P<0.05)③免疫因子聯閤療法治療後可改善和消除免疫性甲狀腺疾病各種臨床癥狀、體徵,治療組優于對照組。結論:兩組治療方法對免疫性甲狀腺疾病都有一定的改善作用,但治療組總有效率和治愈率明顯優于對照組。說明免疫因子聯閤療法治療免疫性甲狀腺疾病療效更佳。
목적:관찰운용면역인자연합요법치료면역성갑상선질병적림상료효。방법:엄격안조납입표준장116례자신면역성갑상선질병환자수궤분2조,치료조58례,대조조58례。채용면역인자연합요법치료,채용상규항갑상선약물치료。량조료정균위3개월。관찰환자치료전후림상증상、체정화실험실화험、검사지표변화。결과:①량조환자치료후유효솔분별시98.3%화53.4%,림상치유솔분별시94.8%화43.1%,치료조명현우우대조조,차차이성유통계학의의(P<0.05)。②면역인자연합요법치료후갑상선항체하강(P<0.05)③면역인자연합요법치료후가개선화소제면역성갑상선질병각충림상증상、체정,치료조우우대조조。결론:량조치료방법대면역성갑상선질병도유일정적개선작용,단치료조총유효솔화치유솔명현우우대조조。설명면역인자연합요법치료면역성갑상선질병료효경가。
Objective: To investigate the combination therapy of immune factors for autoimmune thyroid disease. Methods: 116 patients with autoimmune thyroid disease were randomly divided into two groups, 58 cases for each. The combined therapy was given to the treatment group, and the conventional antithyroid treatment was given to control group. Clinical symptoms, signs and laboratory tests before and after treatment were recorded. Results:①After treatment the efficiency were 98.3% and 53.4%,clinical efficacy were 94.8% and 43.1% in the treatment group than the control group, and the difference was statistically significant (P<0.05).② with immune factors combination therapy, thyroid antibody decreased (P<0.05).③immune factors in combination therapy can improve and eliminate all kinds of clinical symptoms, signs in autoimmune thyroid disease, more in the treatment group than the control group. Conclusion: Immune factors combination therapy for autoimmune thyroid disease show better effect.